chartexchange

QTRX
Quanterix Corporation Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:57:37 PM EST
1.93USD-6.522%(-0.14)1,710,997
Pre-marketNov 19, 2026 9:05:30 AM EST
2.04USD-1.449%(-0.03)
1.9300Bid1.9400Ask0.0100Spread
Loading…
Loading…
Healthcare
Medical Devices
HQ
Billerica, MA, USA
Previous Close
$2.07
Beta
2.13
52-Week High
$8.77 2026-01-09
52-Week Low
$2.05 2026-11-18
SMA 50
$3.04
SMA 200
$3.61
Avg. Vol 10D
893,009
Avg. Vol 30D
589,627
Avg. Vol 90D
719,915
Relative Vol
2.90
38.17M
0.4700%
10,545
QTRX Profile

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).

QTRX Performance
PeriodPriceDateChangeBeta
1W2.862026-11-12-32.34%-7.178
1M2.772026-10-19-30.14%2.619
3M2.962026-08-19-34.63%2.156
6M2.512026-05-19-22.91%2.290
1Y5.862025-11-19-66.98%2.126
2Y11.062024-11-19-82.50%—
5Y46.122021-11-19-95.80%1.869
QTRX Stock Summary

Quanterix Corporation Common Stock (NASDAQ:QTRX) stock price today is $1.94, and today's volume is 1,708,849. QTRX is down 6.522% today. The 30 day average volume is 589,627. QTRX market cap is $91.87M with 47.48M shares outstanding.